Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy

Gene Therapy

Volumn 3, Issue 4, 1996, Pages 350-356

  Liang, X ^a   Hartikka, J ^a   Sukhu, L ^a   Manthorpe, M ^a   Hobart, P ^a  

^a VICAL INC   (United States)

Author keywords

Gene therapy; MERVs; Plasmid vectors; Tetracycline

Indexed keywords

ANTIBIOTIC AGENT; TETRACYCLINE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE;

ANIMALS; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYTOMEGALOVIRUS; DNA, RECOMBINANT; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUSCLES; PLASMIDS; RECOMBINANT FUSION PROTEINS; TETRACYCLINE; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

ANIMALIA; CYTOMEGALOVIRUS; EUKARYOTA;

EID: 0029965148     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wolff JA et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-1468.
2. Davis HL, Michel ML, Whalen RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 1993; 2: 1847-1851.
3. Manthorpe M et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther 1993; 4: 419-431.
4. Ulmer JB, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745-1749.
5. Sedegah M, Hedstrom R, Hobart P, Hoffman SL. Protection against malaria by immunization with plasmid DNA encoding cirumsporozoite protein. Proc Natl Acad Sci USA 1994; 91: 9866-9870.
6. Nabel G et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993; 90: 11307-11311.
7. Hawkins R et al. Genetic approach to idiotypic vaccination. J Immunology 1993; 14: 273-278.
8. Conry R et al. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Therapy 1995; 2: 59-65.
9. Yoshimura K et al. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res 1992; 20: 3233-3240.
10. Acsadi G et al. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 1991; 352: 815-818.
11. Perales J et al. Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc Natl Acad Sci USA 1994; 91: 4086-4090.
12. Felgner PL, Rhodes G. Gene therapeutics. Nature 1991; 349: 351-352.
13. Lew D et al. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum Gene Ther 1995; 6: 553-564.
14. Horn N, Meek J, Budahazi G, Marquet M. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum Gene Ther 1995; 6: 565-573.
15. Parker S et al. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates. Hum Gene Ther 1995; 6: 575-590.
16. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
17. Jans D, Jans P. Negative charge at the casein kinase II site flanking the nuclear localization signal of the SV40 large T-antigen is mechanistically important for enhanced nuclear import. Oncogens 1994; 9: 2961-2968.
18. Gatz C, Frohberg C, Wendenburg R. Stringent repression and homogeneous de-repression by tetracycline of a modified CaMV 35S promoter in intact transgenic tobacco plants. Plant J 1992; 2: 397-404.
19. Elroy-Stein O, Fuerst T, Moss B. Proc Natl Acad Sci USA 1989; 86: 6126-6130.
20. Morgan T, et al. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res 1992; 20: 1293-1299.
21. Chapman BS, Thayer RM, Vincent KA, Haigwood NL. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res 1991; 19: 3979-3986.
22. Choi T, Huang M, Gorman C, Jaenisch R. A generic intron increases gene expression in transgenic mice. Mol Cell Biol 1991; 11: 3070-3074.
23. Kalderon D, Roberts B, Richardson W, Smith A. Cell 1984; 39: 499-509.
24. Deuschle U, Meyer W, Thiesen H-J. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol 1995; 15: 1907-1914.
25. Furth PA et al. Temporal control of gene expression in transgenic mice by a tetracyline-responsive promoter. Proc Natl Acad Sci USA 1994; 91: 9302-9306.
26. Fishman GI, Kaplan ML, Buttrick PM. Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest 1994; 93: 1864-1868.
27. Felgner JH et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994; 269: 2550-2561.
28. Sambrook J, Frisch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989.
29. Sankaran L. A simple quantitative assay for chloramphenicol acetyltransferase by direct extraction of the labeled product into scintillation cocktail. Anal Biochem 1992; 200: 180-186.